title: Oxidative stress, mitochondrial dysfunction and calcium overload in human lamina cribrosa cells from glaucoma donors.
abstract: OBJECTIVE
  Oxidative stress is implicit in the pathological changes associated with glaucoma. The purpose of this study was to compare levels of oxidative stress in glial fibrillary acid-negative protein (GFAP) lamina cribrosa (LC) cells obtained from the optic nerve head (ONH) region of 5 normal (NLC) and 4 glaucomatous (GLC) human donor eyes and to also examine mitochondrial function and calcium homeostasis in this region of the ONH.
  
  
  METHODS
  Intracellular reactive oxygen species (ROS) production was examined by a thiobarbituric acid reactive substances (TBARS) assay which measures malondialdehyde (MDA), a naturally occurring product of lipid peroxidation and is used as an indicator of oxidative stress. Mitochondrial membrane potential (MMP) and intracellular calcium ([Ca(2+)](i)) levels were evaluated by flow cytometry using the JC-1 (5,5',6,6'-tetrachloro-1,1',3,3'-tetrabenzimidazolecarbocyanine iodide) and fluo-4/AM probes respectively. Anti-oxidant and Ca(2+) transport system gene and protein expression were determined by real time polymerase chain reaction (RT-PCR) using gene-specific primer/probe sets and western immunoblotting, respectively.
  
  
  RESULTS
  Intracellular ROS production was increased in GLC compared to NLC (27.19 ± 7.05 µM MDA versus 14.59 ± 0.82 µM MDA, p < 0.05). Expression of the anti-oxidants Aldo-keto reductase family 1 member C1 (AKR1C1) and Glutamate cysteine ligase catalytic subunit (GCLC) were significantly lower in GLC (p = 0.02) compared to NLC control. MMP was lower in GLC (57.5 ± 6.8%) compared to NLC (41.8 ± 5.3%). [Ca(2+)](i) levels were found to be higher (p < 0.001) in GLC cells compared to NLC. Expression of the plasma membrane Ca(2+)/ATPase (PMCA) and the sodium-calcium (NCX) exchangers were lower, while intracellular sarco-endoplasmic reticulum Ca(2+)/ATPase 3 (SERCA) expression was significantly higher in GLC compared to NLC. Subjection of NLC cells to oxidative stress (200 µM H(2)0(2)) reduced expression of Na(+)/Ca2(+) exchanger 1 (NCX 1), plasma membrane Ca2+ ATPase 1 (PMCA 1), and PMCA 4 as determined by RT-PCR.
  
  
  CONCLUSIONS
  Our data finds evidence of oxidative stress, mitochondrial dysfunction and impaired calcium extrusion in GLC cells compared to NLC cells and suggests their importance in the pathological changes occurring at the ONH in glaucoma. Future therapies may target reducing oxidative stress and / or [Ca(2+)](i).
authors: 1Institute of Ophthalmology, Mater Misericordiae University Hospital, Dublin, Ireland.
authors: E M
authors: EM
authors: McElnea
authors: B
authors: B
authors: Quill
authors: N G
authors: NG
authors: Docherty
authors: M
authors: M
authors: Irnaten
authors: W F
authors: WF
authors: Siah
authors: A F
authors: AF
authors: Clark
authors: C J
authors: CJ
authors: O'Brien
authors: D M
authors: DM
authors: Wallace
references: Cell. 2007 Jun 29;129(7):1337-49
references: 17604722
references: Prog Biophys Mol Biol. 2008 Jan-Apr;96(1-3):377-98
references: 17959231
references: Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6387-93
references: 20592232
references: Invest Ophthalmol Vis Sci. 2009 Feb;50(2):717-28
references: 18952924
references: Biochim Biophys Acta. 1998 Aug 10;1366(1-2):33-50
references: 9714722
references: Exp Eye Res. 2007 Mar;84(3):444-54
references: 17173895
references: Aging Cell. 2007 Jun;6(3):297-305
references: 17517040
references: Curr Eye Res. 2010 Apr;35(4):295-301
references: 20373896
references: Biochem J. 2006 Feb 15;394(Pt 1):27-33
references: 16250893
references: Br J Ophthalmol. 2006 Mar;90(3):262-7
references: 16488940
references: Nat Rev Mol Cell Biol. 2003 Jul;4(7):517-29
references: 12838335
references: J Neurosci. 2000 Oct 1;20(19):7208-19
references: 11007877
references: Cell Calcium. 2000 Nov-Dec;28(5-6):285-96
references: 11115368
references: Molecules. 2010 Mar 03;15(3):1168-95
references: 20335972
references: Exp Eye Res. 2011 Aug;93(2):133-40
references: 20708001
references: Exp Eye Res. 2010 Jun;90(6):750-7
references: 20359479
references: Ann N Y Acad Sci. 2007 Mar;1099:436-9
references: 17446483
references: Glia. 2005 Dec;52(4):309-24
references: 16078232
references: Mol Vis. 2005 Sep 23;11:798-810
references: 16205625
references: Mol Vis. 2009;15:76-88
references: 19145252
references: Ann N Y Acad Sci. 2007 Mar;1099:226-36
references: 17446463
references: Basic Life Sci. 1988;49:1029-33
references: 2854973
references: Free Radic Biol Med. 2004 Sep 15;37(6):803-12
references: 15384194
references: Invest Ophthalmol Vis Sci. 1989 Jul;30(7):1633-7
references: 2545647
references: Biochim Biophys Acta. 1998 Sep 23;1374(1-2):34-46
references: 9814850
references: Exp Eye Res. 2011 Aug;93(2):120-32
references: 20849846
references: Invest Ophthalmol Vis Sci. 2000 Sep;41(10):3176-82
references: 10967081
references: Ophthalmic Res. 2010;44(3):173-8
references: 20829641
references: J Biol Chem. 1991 Aug 15;266(23):15068-74
references: 1678388
references: Free Radic Biol Med. 2005 Aug 1;39(3):365-73
references: 15993335
references: J Pathol. 2007 Jan;211(2):181-7
references: 17200950
references: Mutat Res. 2006 Mar;612(2):105-14
references: 16413223
references: Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1115-22
references: 11830654
references: Nat Rev Mol Cell Biol. 2000 Oct;1(1):11-21
references: 11413485
references: Ann N Y Acad Sci. 2002 Nov;976:1-10
references: 12502528
references: Prog Brain Res. 2008;173:353-73
references: 18929121
references: Invest Ophthalmol Vis Sci. 2007 Feb;48(2):705-14
references: 17251469
references: Arch Biochem Biophys. 1992 Sep;297(2):265-70
references: 1497346
references: Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3177-87
references: 16123417
references: Cell. 1997 Jun 27;89(7):1145-53
references: 9215636
references: J Biol Chem. 1995 Dec 15;270(50):29644-7
references: 8530347
references: Br J Ophthalmol. 2006 Mar;90(3):367-71
references: 16488964
references: Invest Ophthalmol Vis Sci. 2000 Oct;41(11):3451-9
references: 11006238
references: Cell Calcium. 2005 Sep-Oct;38(3-4):281-9
references: 16102821
references: Invest Ophthalmol Vis Sci. 2001 Sep;42(10):2315-23
references: 11527945
references: J Glaucoma. 2009 Feb;18(2):93-100
references: 19225343
references: Am J Physiol Cell Physiol. 2007 Sep;293(3):C938-50
references: 17494627
references: Biochim Biophys Acta. 2009 Jun;1793(6):933-40
references: 19010359
references: Biochem J. 2004 Jul 1;381(Pt 1):87-96
references: 15015936
references: Br J Ophthalmol. 1997 Apr;81(4):314-8
references: 9215062
references: Invest Ophthalmol Vis Sci. 2004 Nov;45(11):4049-59
references: 15505055
references: Mol Cell Biochem. 2000 Jan;203(1-2):17-21
references: 10724328
references: Am J Ophthalmol. 2004 Jan;137(1):62-9
references: 14700645
references: Glia. 2002 Apr 1;38(1):45-64
references: 11921203
references: J Biol Chem. 2000 Nov 17;275(46):35902-7
references: 10998414
references: Free Radic Biol Med. 1999 Oct;27(7-8):810-21
references: 10515585
references: Surv Ophthalmol. 2001 May;45 Suppl 3:S277-83; discussuin S295-6
references: 11377449
references: Pflugers Arch. 2009 Jan;457(3):657-64
references: 18548270
references: Invest Ophthalmol Vis Sci. 2009 Jan;50(1):194-202
references: 18775862
references: Invest Ophthalmol Vis Sci. 1998 Mar;39(3):471-5
references: 9501855
references: Muscle Nerve. 2007 Apr;35(4):430-42
references: 17286271
references: Biochem J. 1992 Jun 1;284 ( Pt 2):507-12
references: 1599435
references: Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4912-22
references: 18614807
references: J Physiol. 1992 Sep;455:623-40
references: 1484365
references: Prog Brain Res. 2008;173:339-52
references: 18929120